UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
British journal of ophthalmology, ISSN 0007-1161, 12/2014, Volume 98, Issue 12, pp. 1636 - 1641
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Prospective Studies | Enzyme-Linked Immunosorbent Assay | Intravitreal Injections | Humans | Vascular Endothelial Growth Factor A - blood | Half-Life | Biological Availability | Male | Angiogenesis Inhibitors - pharmacokinetics | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Tissue Distribution | Vitreous Body - metabolism | Wet Macular Degeneration - metabolism | Antibodies, Monoclonal, Humanized - pharmacokinetics | Receptors, Vascular Endothelial Growth Factor - pharmacokinetics | Recombinant Fusion Proteins - pharmacokinetics | Ranibizumab | Female | Aged | Research | Pharmacokinetics | Vascular endothelial growth factor | Analysis | Macular degeneration | Studies | Oncology | Diabetes | Drug dosages | Molecular weight | Index Medicus | Retina | 1506 | Clinical Science
Journal Article
JAMA ophthalmology, ISSN 2168-6165, 06/2017, Volume 135, Issue 6, pp. 558 - 568
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Severity of Illness Index | Diabetic Retinopathy - drug therapy | Bevacizumab - administration & dosage | Follow-Up Studies | Intravitreal Injections | Humans | Treatment Outcome | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Visual Acuity | Disease Progression | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Diabetic Retinopathy - physiopathology | Dose-Response Relationship, Drug | Diabetic Retinopathy - diagnosis | Angiogenesis Inhibitors - administration & dosage | Time Factors | Ranibizumab - administration & dosage | Retrospective Studies | Retina - pathology | Recombinant Fusion Proteins - administration & dosage | Drug therapy | Diabetic retinopathy | Index Medicus | Abridged Index Medicus | Online First | Original Investigation | Research
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2006, Volume 113, Issue 3, pp. 363 - 372.e5
Biological and medical sciences | Miscellaneous | Medical sciences | Ophthalmology | Retina - drug effects | Choroidal Neovascularization - diagnosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Choroidal Neovascularization - etiology | Male | Retinal Detachment - drug therapy | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Bevacizumab | Antibodies, Monoclonal, Humanized | Choroidal Neovascularization - drug therapy | Retinal Detachment - diagnosis | Aged, 80 and over | Vitreous Body | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Fluorescein Angiography | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Fovea Centralis | Macular Degeneration - complications | Vascular Endothelial Growth Factor A - immunology | Visual Acuity | Choroidal Neovascularization - physiopathology | Pigment Epithelium of Eye | Injections | Antibodies, Monoclonal - administration & dosage | Papilledema - diagnosis | Aged | Retina - pathology | Papilledema - drug therapy | Macular degeneration | Physiological aspects | Eye diseases | Angiogenesis inhibitors | Index Medicus
Journal Article
Physical chemistry chemical physics : PCCP, ISSN 1463-9076, 12/2017, Volume 19, Issue 47, pp. 3279 - 3285
Physical Sciences | Chemistry | Physics, Atomic, Molecular & Chemical | Chemistry, Physical | Physics | Science & Technology | Encapsulation | Nanotubes | Coercivity | Soft x rays | Carbon nanotubes | Iron | Electron microscopy | Substrates | Nanoparticles | Surface stability | BCC metals | Remanence | Magnetic properties
Journal Article
5.
Full Text
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2006, Volume 113, Issue 10, pp. 1695 - 1705.e6
Miscellaneous | Diabetes. Impaired glucose tolerance | Retinopathies | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Ophthalmology | Endocrine pancreas. Apud cells (diseases) | Diabetic Retinopathy - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Capillary Permeability - drug effects | Antibodies, Monoclonal - therapeutic use | Male | Bevacizumab | Antibodies, Monoclonal, Humanized | Diabetic Retinopathy - diagnosis | Angiogenesis Inhibitors - administration & dosage | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Vitreous Body | Adult | Female | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Fluorescein Angiography | Iris - blood supply | Retinal Neovascularization - diagnosis | Neovascularization, Pathologic - diagnosis | Tomography, Optical Coherence | Vascular Endothelial Growth Factor A - immunology | Visual Acuity | Injections | Antibodies, Monoclonal - administration & dosage | Neovascularization, Pathologic - drug therapy | Aged | Retinal Neovascularization - drug therapy | Diabetic retinopathy | Care and treatment | Angiogenesis inhibitors | Neovascularization | Consulting services | Index Medicus
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2013, Volume 120, Issue 10, pp. 2035 - 2041
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Choroidal Neovascularization - epidemiology | Intravitreal Injections | Humans | Middle Aged | Male | Macular Degeneration - drug therapy | Bevacizumab | Incidence | Dose-Response Relationship, Drug | Choroidal Neovascularization - drug therapy | Choroidal Neovascularization - pathology | Ranibizumab | Serine Endopeptidases - genetics | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Complement C3 - genetics | Genetic Predisposition to Disease | Antibodies, Monoclonal, Humanized - therapeutic use | Macular Degeneration - complications | High-Temperature Requirement A Serine Peptidase 1 | Genotype | Proteins - genetics | Macular Degeneration - genetics | Aged | Polymorphism, Single Nucleotide | Complement Factor H - genetics | Choroidal Neovascularization - genetics | Cohort Studies | Macular degeneration | Clinical trials | Physiological aspects | Neovascularization | Comparative analysis | Drug therapy | Consulting services | Index Medicus
Journal Article
Retina (Philadelphia, Pa.), ISSN 0275-004X, 10/2017, Volume 37, Issue 10, pp. 1847 - 1858
anti-VEGF | pharmacokinetics | retinal vein occlusion | age-related macular degeneration | diabetic macular edema | Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Diabetic Retinopathy - drug therapy | Prospective Studies | Follow-Up Studies | Intravitreal Injections | Ranibizumab - pharmacokinetics | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Angiogenesis Inhibitors - administration & dosage | Female | Recombinant Fusion Proteins - administration & dosage | Bevacizumab - administration & dosage | Enzyme-Linked Immunosorbent Assay | Vascular Endothelial Growth Factor A - blood | Bevacizumab - pharmacokinetics | Angiogenesis Inhibitors - pharmacokinetics | Macular Edema - blood | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Wet Macular Degeneration - diagnosis | Diabetic Retinopathy - blood | Wet Macular Degeneration - drug therapy | Recombinant Fusion Proteins - pharmacokinetics | Macular Edema - drug therapy | Wet Macular Degeneration - blood | Ranibizumab - administration & dosage | Aged | Drug therapy | Retinal diseases | Index Medicus | Original Study
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2008, Volume 115, Issue 10, pp. e47 - e54
Ophthalmology | Prospective Studies | Retinal Vein Occlusion - diagnosis | Tomography, Optical Coherence | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Treatment Outcome | Visual Acuity | Retinal Vein Occlusion - complications | Antibodies, Monoclonal, Humanized | Macular Edema - etiology | Injections | Pilot Projects | Antibodies, Monoclonal - administration & dosage | Macular Edema - diagnosis | Macular Edema - drug therapy | Ranibizumab | Aged, 80 and over | Vitreous Body | Adult | Female | Aged | Fluorescein Angiography | Index Medicus
Journal Article
Retina (Philadelphia, Pa.), ISSN 0275-004X, 04/2007, Volume 27, Issue 4, pp. 419 - 425
Intravitreal | Macular edema | Branch retinal vein occlusion | Avastin | Bevacizumab | Tomography, Optical Coherence | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Visual Acuity | Retinal Vein Occlusion - complications | Antibodies, Monoclonal, Humanized | Macular Edema - etiology | Injections | Retinal Vein Occlusion - drug therapy | Macular Edema - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Vitreous Body | Adult | Female | Aged | Retrospective Studies | Fluorescein Angiography | Index Medicus
Journal Article
DNA research, ISSN 1340-2838, 2016, Volume 23, Issue 5, pp. 451 - 466
Ripening | Wine | Cell wall | Stress | Radiation | Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Index Medicus | stress | cell wall | Full Papers | ripening | radiation | wine
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2009, Volume 116, Issue 6, pp. 1225 - 1225.e1
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Humans | Risk Factors | Antibodies, Monoclonal - adverse effects | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Aptamers, Nucleotide - adverse effects | Endophthalmitis - etiology | Macular Degeneration - drug therapy | Bevacizumab | Anti-Bacterial Agents - therapeutic use | Antibodies, Monoclonal, Humanized | Injections | Ranibizumab | Vitreous Body | Endophthalmitis - diagnosis | Drug Therapy, Combination | Angiogenesis Inhibitors - adverse effects | Cohort Studies | Endophthalmitis - drug therapy | Index Medicus
Journal Article
ACS nano, ISSN 1936-0851, 09/2015, Volume 9, Issue 9, pp. 8697 - 8709
gold | adatom | dimethyl sulfoxide | DMSO | photoemission spectroscopy | density functional theory | scanning tunneling microscopy | Physical Sciences | Chemistry | Materials Science | Nanoscience & Nanotechnology | Technology | Materials Science, Multidisciplinary | Science & Technology - Other Topics | Chemistry, Multidisciplinary | Chemistry, Physical | Science & Technology | Terminations | Gold | Scanning tunneling microscopy | Charging | Mathematical analysis | Dimethyl sulfoxide | Nanostructure | Photoelectron spectroscopy
Journal Article